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Abstract 
Background: Sleep disturbances, including insomnia and sleep disordered breathing, are a 
common complaint in people with heart failure and impair well-being.  Exercise training (ET) 
improves quality of life in stable heart failure patients. ET also improves sleep quality in healthy 
older patients, but there are no previous intervention studies in heart failure patients.  
 
Aim: This aim of this study was to examine the impact of ET on sleep quality in patients recently 
discharged from hospital with heart failure.   
 
Methods:  Sub-study of a multisite randomised controlled trial.  Participants with a heart failure 
hospitalisation were randomised within 6 weeks of discharge to a 12 week disease 
management programme including exercise advice (n=52) or to the same programme with twice 
weekly structured exercise training (n=54).  ET consisted of two one hour supervised aerobic 
and resistance training sessions, prescribed and advanced by an exercise specialist.  The 
primary outcome was change in Pittsburgh Sleep Quality Index (PSQI) between randomisation 
and week 12.   
 
Results: At randomisation, 45% of participants reported poor sleep (PSQI ≥ 5).  PSQI global 
score improved significantly more in the ET group than the control group (-1.5 ± 3.7 vs. 0.4 ± 
3.8, p=0.03).  Improved sleep quality correlated with improved exercise capacity and reduced 
depressive symptoms, but not with changes in body mass index or resting heart rate.   
 
Conclusion: 12 weeks of twice weekly supervised ET improved sleep quality in patients 
recently discharged from hospital with heart failure.    
 Keywords 
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Introduction 
Poor sleep is a common complaint in heart failure (HF) patients.  More than half of HF patients 
report difficulties initiating or maintaining sleep (1-3) and sleep-disordered breathing has been 
demonstrated in 40-75% (2-4). Insomnia is associated with impairments in daytime function, 
mood and quality of life (1-3, 5), and sleep-disordered breathing has been associated with 
poorer function and a worse prognosis (3, 6).   
 
Exercise training has been shown to improve sleep quality in healthy older adults with sleep 
disturbances (7) and may reduce obstructive sleep apnoea (8). Potential mechanisms for the 
effect of exercise training on sleep quality include improved mood, sympathetic modulation, 
modified cytokine release and increased energy expenditure, which may result in weight 
reduction and ameliorate sleep apnoea (9). While several small studies have suggested that 
exercise training may improve total sleep time (10), sleep efficiency (11) and sleep-disordered 
breathing in HF patients (11-13), there has been little attention to the patient experience of 
sleep in this patient group (14). 
 
The primary objective of this study is to examine the effect of a supervised, hospital-based 
exercise training programme on self-reported sleep quality in heart failure patients.  Secondary 
objectives are to explore the association of sleep quality changes with changes in depressive 
symptoms, exercise capacity, resting heart rate and body weight as potential mediators of 
improved sleep quality.   
 
Methods 
This is a sub-study of the EJECTION-HF randomised controlled trial, which has been described 
in detail previously (15). Study recruitment for this sub-study was carried out between June 
2009 and August 2011. Participants were identified within three hospital heart failure services in 
Queensland, Australia through active screening of Emergency Department, medical and 
cardiology ward admission lists and attendance at team meetings, as well as by physician and 
ward nursing referral. Potential participants were identified by specialist heart failure exercise 
staff at each site and referred to the research team for screening and consent within 6 weeks of 
hospital discharge.  Participants were required to be admitted to hospital with symptomatic HF 
as a dominant clinical diagnosis and be able to regularly attend a 12 week disease 
management program and follow-up appointments. Exclusion criteria included terminal 
diagnosis; serious cognitive impairment precluding consent or adequate participation in the 
intervention; other serious physical impairment which would prevent program attendance and 
participation; implantable cardiac defibrillator (ICD) insertion within 4 weeks of programme 
commencement; cardiac resynchronisation therapy (CRT) within 6 months of programme 
commencement; awaiting cardiovascular procedure (revascularisation or surgery); completed a 
full 12 week regime of formal exercise rehabilitation in the past 12 month period; or not meeting 
safety criteria (refractory chest pain, uncontrolled cardiac arrhythmias, high-degree 
atrioventricular block, pacemakers which do not permit adequate heart rate response to 
exercise, uncorrected primary valvular disease, isolated pulmonary hypertension, poorly 
controlled symptomatic postural hypotension or obstructive cardiomyopathy) (16).  The 
investigation conforms to the principles outlined in the Declaration of Helsinki and was approved 
by Human Research Ethics committees of all participating sites. Written informed consent was 
obtained from all participants. 
 
Baseline assessment included collection of descriptive demographic data, medical history and 
medications from the medical record and baseline measurement of outcome variables (see 
below). Following this assessment, participants were randomly assigned either to a 12 week 
disease management programme (DMP) of education and self-management support including 
standard exercise advice (control), or to the same DMP with the addition of a structured 
exercise training programme designed and supervised by a physiotherapist and/or clinical 
exercise physiologist (intervention).  Randomised allocation was performed by the study 
statistician in blocks of 10 stratified across hospital sites using computer-generated random 
number lists, and provided to the study coordinator in consecutive sealed envelopes. The 
coordinator was not involved in screening or clinical assessments, which were performed by a 
research assistant who remained blinded to group allocation.   
 
Participants randomised to the control arm received a comprehensive DMP from the 
multidisciplinary heart failure service including (1) education on the physiology, medications and 
management of HF; (2) education on the role of exercise in HF and provision of a home-based 
graduated exercise programme; (3) written materials to support education; (4) telephone, clinic 
and/or in-home follow-up to monitor symptoms and response to therapy; (5) medication titration 
(if appropriate) according to protocols and in consultation with physician; and (6) a patient diary 
for recording weight, medications and symptoms. Education was provided both one-to-one and 
in weekly one-hour group sessions for 12 weeks.     
 
Those randomised to the intervention arm received the same DMP as the control group with the 
addition of twice-weekly hospital based supervised group exercise classes of approximately 1 
hour duration for 12 weeks. Classes were based on current evidence-based recommendations 
for HF and consisted of a 10 minute warm-up followed by 20-30 minutes of aerobic exercise 
and 20-30 minutes of concentric and eccentric resistance exercise, balance and stretching.  
Exercises were tailored to the participant’s capabilities.  At the completion of these exercises 
there was a 10 minute cool down period. Exercise prescription followed the FITT guidelines for 
best practice prescription and progression according to ACSM guidelines (16).   
 
Aerobic exercise intensity was measured using the modified 20-point Borg rating of perceived 
exertion (RPE) scale (17).  Participants were instructed to exercise within a RPE range between 
9-13, where 9 was considered fairly light and 13 was considered somewhat hard. Initial 
workloads for the resistance exercises were determined by the prescribing exercise specialist.  
When an individual was able to achieve 3 sets of 10 repetitions with an RPE of 9-13, intensity 
was progressed.  The minimum work to rest ratio was 1:2.   
 
Participants in both study groups were provided with education and written support for a home 
exercise programme in accordance with National Heart Foundation (NHF) guidelines (18).  The 
home programme was prescribed at week one, and was reviewed weekly for the duration of the 
study. The home programme included aerobic and resistance exercises using minimal 
equipment. An exercise goal of a minimum of four sessions per week of 30 minutes duration 
was encouraged. The home program is described in detail in Supplementary Material 1. 
 
Outcome measures 
Outcome and explanatory variables were measured at baseline (randomisation) and week 12. 
Sleep quality was measured using the Pittsburgh Sleep Quality Index (PSQI) (19).  This self-
rated index takes five to ten minutes to complete and assesses sleep quality during the previous 
month.  The survey assesses seven components of sleep quality including subjective sleep 
quality (1 item), sleep latency (2 items), sleep duration (1 item), habitual sleep efficiency (3 
items), sleep disturbances (9 items), use of sleeping medication (1 item) and daytime 
dysfunction (2 items).    Each component score is weighted equally on a 0-3 scale.  The seven 
component scores are summed to give a global PSQI score.  The global PSQI score has a 
range of 0-21 with higher scores indicating worse sleep quality (20).  Scores of 5 or greater 
indicate poor sleep, and previous studies suggest a minimal clinically important difference of 3 
points (19, 21).  
 
Depressive symptoms were measured using the Geriatric Depression Scale (GDS) (22).  This 
validated 15-item questionnaire was specifically developed for use in an unwell, elderly 
populations due to its simple yes/no format.  Exercise capacity was measured using the 6 
minute walk test (6MWT) on a 25 metre walking track (23). This sub-maximal exercise test 
measures the distance an individual is able to walk at a comfortable pace in 6 minutes and has 
been used extensively in HF patients to examine functional capacity because of its simplicity, 
safety and low-cost. Body weight (kg) and height (metres) were assessed using standard 
procedures at each visit to obtain BMI (kg/m2). Resting heart rate was measured by the 
research assistant using standard procedures at each visit. Exercise specialists at each of the 
participating institutions recorded participation in exercise classes across the 3 month period.  
 
Statistical analysis 
Primary analyses were conducted on an intention-to-treat basis.  Differences in patient 
characteristics between study groups were compared using chi squared tests for categorical 
variables and one way analysis of variance (ANOVA) for continuous variables.   
 The primary outcome variable of change in global sleep quality from baseline to week 12 was 
compared between groups using one way analysis of variance, which was also used to examine 
differences for each of the subscales. To enhance clinical meaning, changes was also 
categorised into improved, unchanged or worse sleep at 12 weeks compared to baseline, based 
on the proposed minimal clinically important difference of 3 points, and differences between 
groups compared using chi squared testing.   
 
Univariate analysis using general linear models were used to assess the relationship between 
sleep quality and potential mediating factors (change in depression, exercise capacity, body 
mass index and resting heart rate). Based on the results of univariate analysis, significant 
variables were used as adjusting covariates in analysis of covariance (ANCOVA) to assess 
whether the intervention was an independent modifier of sleep quality after adjusting for a single 
covariate.  
 
Analyses were completed using SPSS, with an alpha level of less than 0.05 considered to 
indicate statistical significance.  Sample size was determined using estimates of effect sizes 
from previous studies (24, 25). In order to demonstrate a mean difference on 3 points on the 
PSQI, with baseline scores between 9.0 and 6.0 (alpha 0.05), it was estimated that a sample 
size of 28 patients in each group would provide 80% power.  Assuming a 20% drop out rate by 
12 weeks, this would require enrolment of 34 patients per group. 
 
Results 
During the study period, 973 patients admitted to participating institutions with a heart failure 
related admission that had been referred to the heart failure service were screened for study 
inclusion (Figure 1).  Seventy-four percent of these were not recruited because eligibility criteria 
were not met (n=712).  Of these patients, 334 (47%) were unable to attend, 169 (24%) were 
unsafe to exercise, 103 (14%) had a serious physical impairment, 36(5%) a serious cognitive 
impairment, 28 (4%) were greater than 6 weeks from hospital admission, 22 (3%) had a life 
expectancy of less than 6 months, 20 (3%) were awaiting cardiovascular surgery or procedure. 
Ten patients were not able to participate for other reasons such as history of non-compliance, 
completed exercise program within past 12 month period, discharged to non-participating HF 
service. In order to determine potential participants’ eligibility in the study the research assistant 
collaborated with treating heart failure clinicians. Where the patient had a history of non-
compliance with heart failure treatment or recommendations and where the treating team did 
not believe they would comply with or attend an exercise program they were not approached for 
participation in the study (n=3). 
 
A further 139 eligible patients chose not to participate.  Six patients did not complete a baseline 
PSQI and were therefore not included in the study. One hundred and six individuals (11 %) 
were randomised: 54 to intervention and 52 to control.  No participants officially withdrew from 
the study during the intervention period.  Twenty-six participants (10 intervention, 16 control) 
were lost to follow-up.  Four participants (4%) died (1 myocardial infarction, 3 arrhythmia), 1 
(1%) was unable to attend due to illness, 2 (2%) returned to work and 19 (18%) did not attend 
due to time commitments or inconvenience.  .There were no significant differences in the 
characteristics of patients who completed the study and those that were lost to follow-up. The 
median attendance at scheduled exercise classes was 16 sessions over 12 weeks (IQR 10-21). 
A summary of randomisation, patient flow and retention through the course of the trial is shown 
in Figure 1. No exercise related adverse events were experienced by any participants during the 
study.   
 
Baseline characteristics of patients in each of the study groups are shown in Table 1. Most 
participants were male and Caucasian with NYHA class 2 symptoms. A quarter (25%) had 
preserved left ventricular function (EF ≥45%). Groups were similar except for slightly lower use 
of key evidence –based medications in the intervention group.   Almost 40% of participants had 
depressive symptoms, and the majority (80%) were overweight or obese (BMI ≥25).  
 
Using a PSQI cut-off of ≥5, 45% of participants reported poor sleep quality at baseline. Poor 
sleep was more likely in females (71% of females reported poor sleep versus 40% of males, 
p=0.005), and those with severe (class IV) heart failure symptoms (92% class IV patients vs. 
40% class I-III, p=0.001). Participants with poor baseline sleep quality also reported significantly 
worse depression scores (mean (SD) GDS good sleepers 3.6 (3.1) vs. 6.1 (3.9) poor sleepers, 
p<0.001).  
 
Participants allocated to intervention had a significantly greater improvement in global sleep 
quality and in the component scores for sleep quality and sleep disturbance (Table 2). The 
greater improvement in the sleep disturbance component was driven largely by reduced 
difficulty breathing at night.  The mean difference between groups was smaller than the minimal 
clinically significant difference (3 points). However, analysis by category showed that 
participants in the intervention group were significantly more likely to have a clinically 
meaningful improvement of 3 or more points, and less likely to have a meaningful deterioration, 
than the control group (p=0.016) (Figure 2).   
 
Improvements in global sleep quality between baseline and week 12 correlated with 
improvements in geriatric depression score (p<0.001) and exercise performance (p=0.04), but 
not changes in BMI (p=0.55) or resting heart rate (p=0.99) (Figure 3).  The intervention was 
associated with a statistically significant (p=0.016) mean improvement of 2 points on the global 
PSQI score, after adjustment for improvements in depression and exercise performance (Table 
3).  
 
Discussion 
In this randomised controlled trial, almost one half of participants reported poor sleep, similar to 
previous studies in heart failure patients (1, 3, 5). Those with poorer sleep were more likely to 
be female, with more advanced heart failure and more depressive symptoms. These 
characteristics have been shown to predict poorer exercise tolerance (26) and lower 
participation in exercise rehabilitation in HF patients (27).  
 
Structured exercise training improved global sleep quality in this trial. Improvements in self-
reported global sleep quality with exercise training have been demonstrated in previous 
controlled intervention studies of middle-aged and older adults with sleep disturbances (7). No 
previous controlled intervention study in heart failure patients has assessed sleep quality. A 
small trial of an outdoor walking programme found improvements in total sleep time measured 
by actigraphy and improved quality of life, although the increased light exposure with outdoor 
exercise is a potential confounder (10). Several studies have documented improvements in 
obstructive and/or central sleep apnoea with aerobic or mixed aerobic/resistance training, 
independent of changes in body mass index (11-13), which may explain the reductions seen in 
sleep disturbance sub-scores in our study. These studies have also demonstrated 
improvements in heart failure biomarkers and muscle sympathetic nerve activity in the exercise 
groups. An uncontrolled cohort study of intensive supervised exercise training in patients with 
cardiac disease (including coronary disease and acute heart failure) reported improvements in 
PSQI global scores as well as depressive symptoms, exercise capacity and BMI (14). 
 
We recognise a number of limitations in this study. Firstly, the study only enrolled recently 
hospitalised heart failure patients, who may report a higher rate of sleep disturbance, and 
generalisablity may be limited by the relatively low consent rates which are common in complex 
intervention studies in older ill populations. However, rates of poor sleep are similar to those 
reported in previous cohort studies in heart failure (1, 3, 5) and our sample included women, 
elderly patients and those with preserved systolic function who are often excluded from 
research studies, providing a reasonably representative patient sample. Secondly, fewer 
patients in the control arm completed follow-up, partly due to higher observed mortality. This 
would be expected to result in sicker patients in the intervention follow-up group, which would 
reduce the magnitude of any measured benefits. Thirdly, the benefits of exercise in heart failure 
are well accepted and so it was not ethical to prevent the control group from exercising. Almost 
three quarters of participants self-reported meeting physical activity guidelines at three month 
follow-up, and this contamination effect combined with incomplete adherence in the exercise 
training group would also tend to reduce the observed difference between groups. Fourthly, the 
intervention group received twice weekly contact with programme staff (compared to once 
weekly for the control group), and this increased social contact may have had a confounding 
effect on outcomes including depression and sleep. It may also have resulted in changes in 
medication use, although the high rates of evidence-based heart failure prescribing in both 
groups at baseline make it unlikely that this would be a major source of bias. Finally, the self-
report instrument used may be subject to bias and outcome expectancy in an intervention 
where participants could not be blinded. The study would be strengthened by concurrent 
objective measures of sleep and the functional outcomes of poor sleep such as daytime 
sleepiness and fatigue. Objective measurement of sleep and wake cycles through actigraphy 
presents a cheap, unobtrusive way to measure sleep in the home setting.  
 
Despite these weaknesses, this study demonstrates the potential of exercise training to produce 
meaningful improvement in poor sleep, which is an important and common adverse symptom in 
heart failure patients. This information may motivate heart failure patients with poor sleep to 
participate in exercise rehabilitation, and encourage greater referral to established exercise 
rehabilitation programmes by health professionals for this vulnerable patient group.  Larger, well 
designed trials to assess objective and subjective measures of sleep disturbance and its 
consequences will help to clarify the emerging role of exercise training as an important non-
pharmacological therapy for heart failure.  
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